Sponsor or institution

Clinical trials and research at Materia Medica Holding

As of November 12, 2026, Find a Trial lists 4 clinical trials run by Materia Medica Holding that are recruiting, in Russia. By phase: Phase 3 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Raphamin for acute bronchitis in adults Phase 3 Aramil and 32 other locations Recruiting Jun 16, 2026
Rengalin liquid for dry cough in children aged 6 months to 3 years Phase 3 Gatchina and 29 other locations Recruiting Sep 12, 2025
Testing Raphamin for treating acute rhinosinusitis in adults Phase 3 Aramil and 43 other locations Recruiting Mar 28, 2025
Efficacy and safety of Raphamin for treating respiratory infections in children Phase 3 Gatchina and 34 other locations Recruiting Dec 4, 2024

All recruiting trials (4)

Quick answers

How many clinical trials run by Materia Medica Holding are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in Russia. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 4. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.